2023 Partners
Luxna Biotech
Event Partner
Luxna Biotech is an antisense drug development company. Core technologies are novel artificial nucleoside Bridged Nucleic Acid (named AmNA®, scpBNA® and GuNA®) and 5’-modified DNA (5’-CPTM). Our research focus on how to manage the acute and delayed neurotoxicity using our modifications, we found several antisense can minimize the neurotoxicity risk. Combined with our Gapmer and SSO integrated discovery platform LuxiAPTM, we are looking for the antisense collaborated development partner and technologies out-license opportunity.
